Technical improvements in the staging of cancer: The role of imaging and contrast agents

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 22, Issue 2, 1994, Pages 285-294

  Wolf, G L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; BLOOD; CELLS; CHARACTERIZATION; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; METABOLISM; ONCOLOGY; PHARMACOKINETICS; TISSUE;

BIOPSY; CANCER DIAGNOSIS; CELL TYPE; CONTRAST AGENTS; LYMPH NODES; OXYGENATION; PERFLUOROCARBON LYMPHOGRAPHY; PERFUSION;

MEDICAL IMAGING;

CONTRAST MEDIUM; FLUOROCARBON;

BIOPSY; CANCER STAGING; CELL TYPE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; IMAGING; LYMPH NODE; LYMPHOGRAPHY; LYMPHOMA; METASTASIS; OXYGENATION; PERFUSION;

ANIMAL; COMPARATIVE STUDY; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMAN; NEOPLASM STAGING; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0028434175     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199409117421     Document Type: Article

References (12)

1. G. Wolf, D. Long, J. Riess. Percutaneous lymphography with PFOB. Radiology 177(P):366, (1990).
2. G.L. Wolf. Indirect lymphography with radioopaque nanoparticulates. Radiology 185(P):115, (1992).
3. N. Weidner, J. Folkman, F. Pozza, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, (1992).
4. Y. Boucher, R.K. Jain. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52:5110-5114, (1992).
5. C.J. Eskey, A.P. Koretsky, M.M. Domach, R.K. Jain. 2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 52:6010-6019, (1992).
6. G.E.H. Kuhnle, M. Dellian, S. Walenta, W. Mueller-Klieser, A.E. Guetz. Simultaneous high-resolution measurement of adenosine triphosphate levels and blood flow in hamster amelanotic melanoma A-mel-3. J Natl Cancer Inst 84:1642-1647, (1992).
7. P.L. Davis, G.L. Wolf, J. Gillen. Indicator dilution time-activity curves demonstrated by rapid magnetic resonance imaging techniques and paramagnetic contrast agent. Invest Radiol 24:400-406, (1989).
8. B.R. Rosen, J.W. Belliveau, D. Chien. Perfusion imaging with nuclear magnetic resonance. Magn Reson Q 5:263-281, (1989).
9. G.L. Wolf, J. Rogowska. Contrast agents for fast imaging. Magn Reson Med 22:268-272, (1991).
10. J.P. Stack, O.M. Redmond, M.B. Codd, P.A. Dervan, J.T. Ennis. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 174:491-494, (1990).
11. R.K. Jain. Delivery of novel therapeutic agents in tumors: physiologic barriers and strategies. J Natl Cancer Inst 81:570-576, (1989).
12. J. Kenney, U. Schmiedl, K. Maravilla, F. Starr, M. Graham, A. Spence, J. Nelson. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium DTPA. Magn Reson Med 27:68-75, (1992).